Elias Anaissie, M.D., Professor of Medicine Vice Chair and Director of Supportive Care, Myeloma Institute
M.D. University of Paris XII, Creteil
Faculty of Medicine, Paris, France,
and St Joseph University Medical School, Beirut,
Lebanon. Residency (internal medicine), American University of Beirut Medical Center. Fellowship (hematology/oncology), American University of Beirut Medical Center. Fellowship (infectious diseases), University of Texas M.D. Anderson Cancer Center. Associate Professor of Medicine, M.D. Anderson Cancer Center, Houston, Texas. Adjunct Associate Professor of Pathology at University of Texas Medical Branch at
Galveston.
Special
Interest: Prevention and management of the complications of chemotherapy and stem cell transplantation
Selected Publications:
Talamo G, Angtuaco E, Walker RC, Dong L, Miceli MH, Zangari M, Tricot G, Barlogie B, Anaissie EJ. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy. J of Clin Onc. 23(22):5217-23, 2005
Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B, Anaissie EJ. Strong Correlation between Serum Aspergillus Galactomannan and Aspergillosis Outcome in Patients with Hematological Cancer: Clinical and Research Implications. Clin Infect Dis. 2008 May 1;46(9):1412-22
Maertens J, Buvé K, Anaissie E. Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: counterpoint. J Natl Compr Canc Netw. 2008 Feb;6(2):183-9
Woods G, Miceli MH, Grazziutti ML, Zhao W, Barlogie B, Anaissie EJ.Serum Aspergillus galactomannan antigen values strongly correlate with outcome ofinvasive aspergillosis: a study of 56 patients with hematologic cancer.Cancer. 2007 Aug 15;110(4):830-4.
Miceli MH, Maertens J, Buve K, Grazziutti M, Woods G, Rahman M, Barlogie B,Anaissie EJ. Immune reconstitution inflammatory syndrome in cancer patients with pulmonaryaspergillosis recovering from neutropenia: Proof of principle, description, and clinical and research implications. Cancer. 2007 Jul 1;110(1):112-20
Barlogie B, Anaissie E, van Rhee F, Pineda-Roman M, Zangari M, Shaughnessy J, Epstein J, Crowley J.The Arkansas approach to therapy of patients with multiple myeloma. Best Pract Res Clin Haematol. 2007 Dec;20(4):761-81
Having problems
with the site? E-mail the Webmaster.
Copyright 2002-2005, Myeloma Institute for
Research and Therapy, University of Arkansas for Medical Sciences Terms and Conditions of Use
The information on the Myeloma Institute web site
is not intended as a substitute for professional medical attention. The
information is intended only as an aid in understanding current medical
knowledge. A physician should always be consulted for any health concern or
medical condition. The Myeloma Institute web site provides links to other
organizations as a service to our readers. The Myeloma Institute is not
responsible for the information provided on other web sites.